Mikael Pihl
Linkoeping, E, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Regulatory T-Cell Phenotyping Using CyTOF.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 30, 2022
Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes.
Journal: Frontiers in immunology
Published: October 18, 2021
Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets.
Journal: Frontiers in immunology
Published: December 17, 2019
Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes.
Journal: Frontiers in immunology
Published: September 03, 2018
GAD-specific T cells are induced by GAD-alum treatment in Type-1 diabetes patients.
Journal: Clinical immunology (Orlando, Fla.)
Published: November 08, 2016
GAD-treatment of children and adolescents with recent-onset type 1 diabetes preserves residual insulin secretion after 30 months.
Journal: Diabetes/metabolism research and reviews
Published: March 28, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026